The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia Publisher Pubmed

Zafarani A¹ ; Taghavifarahabadi M² ; Razizadeh MH³ ; Amirzargar MR¹ ; Mansouri M⁴ ; Mahmoudi M⁵

Source: Stem Cell Reviews and Reports Published:2023

Abstract

Natural killer (NK) cells are one of the innate immune cells that play an important role in preventing and controlling tumors and viral diseases, but their role in hematopoietic stem cell transplantation (HCT) is not yet fully understood. However, according to some research, these cells can prevent infections and tumor relapse without causing graft versus host disease (GVHD). In addition to NK cells, several studies are about the anti-leukemia effects of NK cell-derived exosomes that can highlight their roles in graft-versus-leukemia (GVL). In this paper, we intend to investigate the results of various articles on the role of NK cells in allogeneic hematopoietic cell transplantation and also their exosomes in GVL. Also, we have discussed the antiviral effects of these cells in post-HCT cytomegalovirus infection. Graphical Abstract: [Figure not available: see fulltext.]. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Related Docs

View other Related Docs

1. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)

2. Natural Killer Cells and Cancer Therapy, What We Know and Where We Are Going, Immunotherapy (2019)

3. The Tricks for Fighting Against Cancer Using Car Nk Cells: A Review, Molecular and Cellular Probes (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (2)

Amir Ali Hamidieh (2)

Other Related Docs

4. Natural Killer Cell-Derived Exosomes for Cancer Immunotherapy: Innovative Therapeutics Art, Cancer Cell International (2023)

5. The Influence of Kir Gene Polymorphisms and Kir-Ligand Binding on Outcomes in Hematologic Malignancies Following Haploidentical Stem Cell Transplantation: A Comprehensive Review, Current Cancer Drug Targets (2023)

6. Natural Killer Cells and Their Exosomes in Viral Infections and Related Therapeutic Approaches: Where Are We?, Cell Communication and Signaling (2023)

7. Car-Engineered Nk Cells; a Promising Therapeutic Option for Treatment of Hematological Malignancies, Stem Cell Research and Therapy (2021)

8. Antileukemia Activity of Human Natural Killer Cell-Derived Nanomagic Bullets Against Acute Myeloid Leukemia (Aml), International Journal of Hematology-Oncology and Stem Cell Research (2024)

9. Unraveling the Dynamic Mechanisms of Natural Killer Cells in Viral Infections: Insights and Implications, Virology Journal (2024)

10. Nk Cells - Dr. Jekyll and Mr. Hyde in Autoimmune Rheumatic Diseases, International Immunopharmacology (2022)

11. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)

12. Natural Killer Cell–Based Immunotherapy: From Transplantation Toward Targeting Cancer Stem Cells, Journal of Cellular Physiology (2018)

13. Mesenchymal Stem Cells and Natural Killer Cells Interaction Mechanisms and Potential Clinical Applications, Stem Cell Research and Therapy (2022)

14. Natural Killer Cells and Killer Cell Immunoglobulin-Like Receptors in Solid Organ Transplantation: Protectors or Opponents?, Transplantation Reviews (2022)

15. Natural Killer Cell-Based Therapies in Neuroblastoma, Cellular Immunology (2025)

16. Investigation of Kir/Hla Relationship and Other Clinical Variables After T-Cell-Replete Haploidentical Bone Marrow Transplantation in Patients With Acute Myeloid Leukemia (Aml), BMC Immunology (2023)

17. Bioactivity of Exosomes Derived From Trained Natural Killer Cells Versus Non-Trained One: More Functional and Antitumor Activity, BioMed Research International (2022)

18. Antigen-Independent Killer Cells Prepared for Adoptive Immunotherapy: One Source, Divergent Protocols, Diverse Nomenclature, Journal of Immunological Methods (2020)

19. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)

20. Natural Killer Cell Epigenetic Reprogramming in Tumors and Potential for Cancer Immunotherapy, Epigenomics (2023)

Style	Citing Format
MLA	Zafarani A, et al.. "The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia." Stem Cell Reviews and Reports, vol. 19, no. 1, 2023, pp. 26-45.
APA	Zafarani A, Taghavifarahabadi M, Razizadeh MH, Amirzargar MR, Mansouri M, Mahmoudi M (2023). The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia. Stem Cell Reviews and Reports, 19(1), 26-45.
Chicago	Zafarani A, Taghavifarahabadi M, Razizadeh MH, Amirzargar MR, Mansouri M, Mahmoudi M. "The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia." Stem Cell Reviews and Reports 19, no. 1 (2023): 26-45.
Harvard	Zafarani A et al. (2023) 'The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia', Stem Cell Reviews and Reports, 19(1), pp. 26-45.
Vancouver	Zafarani A, Taghavifarahabadi M, Razizadeh MH, Amirzargar MR, Mansouri M, Mahmoudi M. The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia. Stem Cell Reviews and Reports. 2023;19(1):26-45.
BibTex	@article{ author = {Zafarani A and Taghavifarahabadi M and Razizadeh MH and Amirzargar MR and Mansouri M and Mahmoudi M}, title = {The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia}, journal = {Stem Cell Reviews and Reports}, volume = {19}, number = {1}, pages = {26-45}, year = {2023} }
RIS	TY - JOUR AU - Zafarani A AU - Taghavifarahabadi M AU - Razizadeh MH AU - Amirzargar MR AU - Mansouri M AU - Mahmoudi M TI - The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia JO - Stem Cell Reviews and Reports VL - 19 IS - 1 SP - 26 EP - 45 PY - 2023 ER -

Science Communicator Platform

Authors

Abstract